Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-07-22, Stock:ABBV, The news for the past five days is as follows:
2021-07-15: nan
2021-07-16: NEWS1: AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA.NEWS2: 7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield.NEWS3: AbbVie, Lilly face fresh delays in FDA approval for expanded use of arthritis drugs.NEWS4: AbbVie Provides Update Regarding RINVOQ® (upadacitinib) for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S..
2021-07-19: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.NEWS2: AbbVie (ABBV) Rinvoq Dermatitis' sNDA Decision Delayed by FDA.NEWS3: Lilly (LLY), Incyte's Decision on Olumiant sNDA Delayed by FDA.
2021-07-20: NEWS1: JNJ Option Traders Ready for Positive Earnings.NEWS2: Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the 2021 ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting.
2021-07-21: NEWS1: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.NEWS2: Here's Why AbbVie (ABBV) is a Strong Momentum Stock.NEWS3: AbbVie (ABBV) Venclexta Gets Breakthrough Therapy Tag for MDS.NEWS4: Venetoclax (VENCLEXTA®) Granted US FDA Breakthrough Therapy Designation (BTD) in Higher Risk Myelodysplastic Syndrome (MDS).

Answer: Rise